Tuesday 3 November 2026
Export UNH’s income statement to Excel — free account
UnitedHealth Group Incorporated
UNH Healthcare Healthcare Plans
UnitedHealth Group Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $447.6 billion, up 11.8% from fiscal 2024.
- Revenue
- −0.41%
- EPS
- +76.1%
- Free cash flow
- −15.7%
- Total debt
- −5.09%
Quarter to September 2026, against a year earlier
399.68
0.76
−0.19%
Follow UNH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
25.03 | 20.44 | 26.75 | 20.96 |
P/S ratio |
0.67 | 0.55 | 0.83 | 0.74 | |
P/FCF ratio |
18.65 | 12.49 | 15.87 | 14.51 | |
P/Operating CF |
270.52 | 27.57 | 33.92 | 64.63 | |
P/B ratio |
2.99 | 2.36 | 3.59 | 3.17 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.77 | 0.64 | 0.92 | 0.83 | |
EV/EBITDA |
14.75 | 12.34 | 15.91 | 14.30 | |
EV/Operating CF |
17.46 | 12.35 | 15.28 | 14.17 | |
EV/FCF |
21.40 | 14.54 | 17.48 | 16.27 | |
Quick Ratio |
0.70 | 0.72 | 0.70 | 0.42 | |
Current Ratio |
0.79 | 0.80 | 0.78 | 0.25 | |
Net Debt/EBITDA |
29.53 | 4.01 | 4.21 | 0.00 | |
Debt/Assets |
23.36% | 22.85% | 22.44% | 21.97% | |
Debt/Equity |
0.72 | 0.69 | 0.67 | 0.66 | |
Asset Turnover |
1.47 | 1.45 | 1.46 | 1.43 | |
Operating CF/Net income |
110.80 | 1.42 | 2.02 | 1.25 | |
Capex/Depreciation |
(0.85) | (0.74) | (0.77) | (0.80) | |
Interest Coverage |
0.39 | 9.41 | 8.31 | 6.82 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.42 | 0.42 | 0.42 | 0.00 | |
Share Based Compensation of Revenue |
0.16% | 0.31% | 0.25% | 0.19% | |
Graham Net Nets |
(0.40) | (0.48) | (0.32) | (0.54) | |
Graham Number |
180.87 | 184.62 | 201.28 | 0.00 | |
Earnings Yield |
4.00% | 4.89% | 3.74% | 4.77% | |
Free Cash Flow Yield |
5.36% | 8.00% | 6.30% | 6.89% | |
Revenue per Share |
124.69 | 123.04 | 124.20 | 0.00 | |
Operating CF per Share |
1.22 | 9.82 | 12.25 | 0.00 | |
Capex per Share |
(1.04) | (0.84) | (0.89) | 0.00 | |
Free Cash Flow per Share |
0.18 | 8.97 | 11.37 | 0.00 | |
Cash per Share |
30.97 | 34.39 | 34.89 | 0.00 | |
Shareholders Equity per Share |
110.23 | 114.42 | 115.87 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
110.23 | 114.42 | 115.87 | 0.00 | |
Free Cash Flow |
160.00 | 8,149.00 | 10,253.00 | 4,264.00 | |
Working Capital |
(24,315.00) | (22,997.00) | (24,960.00) | (87,286.00) | |
Capital Expenditures |
(948.00) | (763.00) | (799.00) | (859.00) | |
Net Current Asset Value |
(118,909.00) | (117,622.00) | (118,354.00) | (180,104.00) | |
EV/EBIT |
18.14 | 15.18 | 19.05 | 15.52 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
15.81 | 13.04 | 17.30 | 13.84 | |
| Other line items | |||||
Average Receivables |
50,584.50 | 52,066.50 | 49,509.50 | 37,988.50 | |
Average Payables |
36,184.50 | 36,098.50 | 37,035.50 | — | |
Average Assets |
303,929.50 | 311,217.00 | 309,150.00 | 314,025.50 | |
Average Common Equity |
99,179.00 | 102,353.00 | 102,491.00 | — |
Columns are period end dates · fundamentals updated 2 Nov 2026